Effect of E3040, an inhibitor of 5-lipoxygenase and thromboxane synthase, on rat bowel damage induced by lipopolysaccharide

Author： Oketani K. Inoue T. Murakami M.

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.427, Iss.2, 2001-09, pp. : 159-166

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In vitro effects of E3040, a dual inhibitor of 5-lipoxygenase and thromboxane A 2 synthetase, on eicosanoid production

By Oketani K. Nagakura N. Harada K. Inoue T.

European Journal of Pharmacology, Vol. 422, Iss. 1, 2001-06 ,pp. : 209-216

Elsevier

Access to resources Recommend Favorite

Effect of a 5-lipoxygenase inhibitor on nerve growth factor-induced thermal hyperalgesia in the rat

By Amann R. Schuligoi R. Lanz I. Peskar B.A.

European Journal of Pharmacology, Vol. 306, Iss. 1, 1996-06 ,pp. : 89-91

Elsevier

Access to resources Recommend Favorite

Effect of anti-inflammatory bowel disease drug, E3040, on urate transport in rat renal brush border membrane vesicles

By Yamada H. Kotaki

European Journal of Pharmacology, Vol. 406, Iss. 1, 2000-10 ,pp. : 45-48

Elsevier

Access to resources Recommend Favorite

Effect of camonagrel, a selective thromboxane synthase inhibitor, on retinal vascularization in experimental diabetes

By De La Cruz J.P. Moreno A. Ruiz-Ruiz M.I. Garca Campos J. Sanchez de la Cuesta F.

European Journal of Pharmacology, Vol. 350, Iss. 1, 1998-05 ,pp. : 81-85

Elsevier

Access to resources Recommend Favorite

Effect of DP-1904, a thromboxane A 2 synthase inhibitor, on passive Heymann nephritis in rats

By Nagao T. Nagamatsu T. Suzuki Y.

European Journal of Pharmacology, Vol. 316, Iss. 1, 1996-11 ,pp. : 73-80

Elsevier

Access to resources Recommend Favorite